We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

SPC U.k. Spac Plc

0.00 (0.0%)
Last Updated: 01:00:00
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Share Name Share Symbol Market Type Share ISIN Share Description
U.k. Spac Plc LSE:SPC London Ordinary Share GB00B3CQW227 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.205 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Gen Contractor-nonres Bldgs 0.0 -4.9 - - 3.80

Hellenic Dynamics PLC Appointment of Katherine Fleming to Advisory Board (2334U)

27/03/2023 7:00am

UK Regulatory (RNS & others)

U.k. Spac (LSE:SPC)
Historical Stock Chart

From Sep 2022 to Sep 2023

Click Here for more U.k. Spac Charts.


RNS Number : 2334U

Hellenic Dynamics PLC

27 March 2023

27 March 2023

Hellenic Dynamics plc

("Hellenic Dynamics" or the "Company")

Appointment of Katherine Fleming to Advisory Board

London, 27 March 2023: Hellenic Dynamics plc (LSE: HELD) a medical cannabis cultivation company, is pleased to announce the appointment of Katherine Fleming to its Advisory Board. Katherine is currently the President and CEO of the J. Paul Getty Trust, the international cultural and philanthropic institution, overseeing its 1,500 employees and US$8.5 billion endowment fund.

Katherine previously held the position of Provost and Professor of History of New York University, the largest private university in the United States by enrolment, where she is also the Alexander S. Onassis Chair of Hellenic Studies. As Provost, she oversaw the University's global academic strategy and was responsible for budgetary allocation. Past international appointments have included serving as President of the Board of the University of Piraeus, Greece and as associate member of the faculty of the École Normale Supérieure in Paris, France.

Katherine holds a number of honours including being named to the French Légion d'Honneur and being decorated by the Greek Government as a commander in the Order of Beneficence. In 2016 Katherine was recognized for her contributions to Greek culture by being granted honorary Greek citizenship.

Katherine will assist Hellenic Dynamics both domestically in Greece with her strong and well-established relationships, as well as on the international stage as it aims to be the dominant supplier of THC medical cannabis products in Europe.

Hellenic Dynamics is a medical cannabis cultivator specifically focused on the cultivation and supply of tetrahydrocannabinol (" THC") dominant strains of medical cannabis flowers destined for the rapidly growing medical cannabis markets across Europe. In December 2022, Hellenic Dynamics became the first medical cannabis cultivator to list on the London Stock Exchange's main market for listed securities.

Davinder Rai, CEO of Hellenic Dynamics, commented:

"We are honoured to have Katherine join our Advisory Board and I personally look forward to working with her. Katherine brings a huge breadth of experience that will benefit Hellenic both domestically in Greece and in wider Europe."

Katherine Fleming, commented:

"I'm delighted to join Hellenic Dynamics, which connects two worlds about which I care deeply: patients for whom medical cannabis can improve their quality of life and outcomes, and Greece - a country with massive potential for being the leader in the European medical cannabis cultivation space."


   Hellenic Dynamics plc                               +44 (0)20 3818 7850 
   Davinder Rai                                              davinder@hellenicdynamics.com 

Cairn Financial Advisers LLP

   Emily Staples / Jo Turner                           +44 (0)20 7213 0880 

Peterhouse Capital

   Lucy Williams / Charles Goodfellow            +44 (0)20 7469 0930 

J&H Communications

   George Hudson                                         +44 (0)7803 603130 

About Hellenic Dynamics plc

Founded in 2019, Hellenic Dynamics is specifically focused on the cultivation and supply of THC ("tetrahydrocannabinol") - dominant strains of medical cannabis flowers, destined for the growing medical cannabis markets across Europe. Hellenic Dynamics' core strategy is to develop and operate its 40,000 square metre active cultivation licence from its 195,506 square metre facility located near Thessaloniki in Northern Greece. In full production, Hellenic Dynamics is capable of producing over 54,000 kg of dried flowers per annum.

Hellenic Dynamics will take advantage of its relatively low cost base resulting from a comparatively low cost of power, having its own running water supply and the labour rates for skilled and semi-skilled labour in Northern Greece.

25 European countries now allow medical cannabis via prescription and the European cannabis market is expected to reach EUR43.3 billion per annum by 2027. Sales of Hellenic Dynamics' dried THC-dominant cannabis flowers and extracts are initially intended for export into Europe's largest market - Germany, in addition to other European markets including domestically in Greece.

As the first medical cannabis cultivator to obtain a listing on the main market for listed securities of the London Stock Exchange, Hellenic is significantly different to the number of CBD (Cannabidiol) related companies that have appeared over the recent years. Hellenic Dynamics cultivates THC-dominant medical cannabis flowers. THC-dominant medical cannabis products are only available via a medical prescription. Medicinal cannabis has been approved for use both in the United Kingdom and Germany, plus 23 other European countries, for conditions including but not limited to chronic pain, intractable chemotherapy-related nausea, anxiety, insomnia, Tourette's syndrome, substance use disorder, multiple sclerosis, IBS, spinal cord treatment, lack of appetite due to HIV/AIDS, cachexia, anorexia and glaucoma.

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi ed by their use of terms and phrases such as "believe", "could", "should" "envisage", "estimate", "intend", "may", "plan", "potentially", "expect", "will" or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements re ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 27, 2023 02:00 ET (06:00 GMT)

1 Year U.k. Spac Chart

1 Year U.k. Spac Chart

1 Month U.k. Spac Chart

1 Month U.k. Spac Chart
Your Recent History
U.k. Spac
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: gb D: 20230929 12:40:24